Understanding the molecular backgrounds of ALK gene rearrangement has been made possible thanks to the wider use of the next-generation sequencing (NGS) technique, which is slowly replacing monogeneous techniques such as fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) techniques in routine genetic diagnosis of NSCLC patients [1]. Here, ALK is linked to non-small cell lung carcinoma.